International Assets Investment Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-64,875
Closed -$56.4K 737
2023
Q2
$56.4K Buy
64,875
+6,475
+11% +$4.62K 0.01% 586
2023
Q1
$40.8K Buy
58,400
+9,570
+20% +$7.75K 0.01% 704
2022
Q4
$40K Buy
48,830
+10,880
+29% +$10.7K ﹤0.01% 759
2022
Q3
$39K Buy
37,950
+3,150
+9% +$5.03K 0.01% 451
2022
Q2
$57 Buy
34,800
+850
+3% +$1.76K 0.01% 440
2022
Q1
$100K Buy
33,950
+2,500
+8% +$8.76K 0.02% 459
2021
Q4
$150K Buy
31,450
+650
+2% +$4.2K 0.03% 475
2021
Q3
$233K Buy
30,800
+3,400
+12% +$21.8K 0.04% 405
2021
Q2
$204K Buy
27,400
+7,780
+40% +$60K 0.04% 435
2021
Q1
$153K Buy
+19,620
New +$196K 0.01% 584

International Assets Investment Management's SURF Position: Q3 2023 in Review

International Assets Investment Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 64,875 shares — an estimated $56.4K sold.

International Assets Investment Management first reported a position in SURF in Q1 2021 and held it in 10 quarters. The position peaked at $233K in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • International Assets Investment Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • International Assets Investment Management sold 64,875 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $56.4K.
  • International Assets Investment Management first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • International Assets Investment Management's Surface Oncology, Inc. Common Stock position peaked at $233K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on International Assets Investment Management's 13F filing for Q3 2023, filed 4 Oct 2023.